Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats
暂无分享,去创建一个
[1] D. Rachoń,et al. Effects of dietary equol on the pituitary of the ovariectomized rats. , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[2] Evan R. Simpson,et al. Of mice and men: the evolving phenotype of aromatase deficiency , 2006, Trends in Endocrinology & Metabolism.
[3] M. Hamrick,et al. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. , 2006, The Journal of nutrition.
[4] U. P. S. T. Force. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. , 2005 .
[5] U. P. S. T. Force,et al. Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendations from the U.S. Preventive Services Task Force , 2005, Annals of Internal Medicine.
[6] A. Arıcı,et al. Phyto-oestrogens and the endometrium , 2004, The Lancet.
[7] J. Katzenellenbogen,et al. Estrogenicity of the Isoflavone Metabolite Equol on Reproductive and Non-Reproductive Organs in Mice1 , 2004, Biology of reproduction.
[8] V. Unfer,et al. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. , 2004, Fertility and sterility.
[9] P. Bandosz,et al. Knowledge and use of hormone replacement therapy among Polish women: estimates from a nationally representative study--HORTPOL 2002. , 2004, Maturitas.
[10] M. Stefanick,et al. Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society. , 2004, Menopause.
[11] D. Kritz-Silverstein,et al. Usual dietary isoflavone intake and body composition in postmenopausal women , 2003, Menopause.
[12] Mary Cushman,et al. Estrogen plus progestin and the risk of coronary heart disease. , 2003, The New England journal of medicine.
[13] W. Banz,et al. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. , 2003, The Journal of nutrition.
[14] K. Setchell,et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. , 2003, The Journal of nutrition.
[15] E. Vittinghoff,et al. Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial , 2003, Annals of Internal Medicine.
[16] H. Jarry,et al. Phytoestrogens for hormone replacement therapy? , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[17] K. Setchell,et al. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. , 2002, The Journal of nutrition.
[18] J. Sorkin,et al. Comparison of VO2max and disease risk factors between perimenopausal and postmenopausal women , 2002, Menopause.
[19] M. Rendell,et al. Effects of Estrogen Replacement Therapy on Abdominal Fat Compartments as Related to Glucose and Lipid Metabolism in Early Postmenopausal Women , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[20] J. Ashby,et al. Critical Review and Evaluation of the Uterotrophic Bioassay for the Identification of Possible Estrogen Agonists and Antagonists: In Support of the Validation of the OECD Uterotrophic Protocols for the Laboratory Rodent , 2002, Critical reviews in toxicology.
[21] B. Nicklas,et al. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. , 2002, Diabetes care.
[22] S. B. Pedersen,et al. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. , 2001, Biochemical and biophysical research communications.
[23] G. Iwamoto,et al. Increased adipose tissue in male and female estrogen receptor-α knockout mice , 2000 .
[24] T. Sellers,et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. , 2000, Archives of internal medicine.
[25] I. Godsland,et al. Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. , 2000, Metabolism: clinical and experimental.
[26] M. J. Toth,et al. Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. , 2000, Diabetes care.
[27] E. Poehlman,et al. Menopause‐Related Changes in Body Fat Distribution , 2000, Annals of the New York Academy of Sciences.
[28] A. Abdel‐Rahman,et al. Effect of long-term ovariectomy and estrogen replacement on the expression of estrogen receptor gene in female rats. , 2000, European journal of endocrinology.
[29] H. Adlercreutz,et al. Interindividual Variation in Metabolism of Soy Isoflavones and Lignans: Influence of Habitual Diet on Equol Production by the Gut Microflora , 2000, Nutrition and cancer.
[30] J. Callés-Escandon,et al. Relation of regional fat distribution to insulin sensitivity in postmenopausal women. , 2000, Fertility and Sterility.
[31] A. Lethaby,et al. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. , 2004, The Cochrane database of systematic reviews.
[32] I Persson,et al. Risk of endometrial cancer following estrogen replacement with and without progestins. , 1999, Journal of the National Cancer Institute.
[33] J. Corton,et al. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.
[34] E. Poehlman,et al. Effects of the menopause transition on body fatness and body fat distribution. , 1998, Obesity research.
[35] Organisation for Economic Cooperation and Development,et al. Organisation for economic cooperation and development , 1998 .
[36] N. Hoggard,et al. Hormonal and neuroendocrine regulation of energy balance--the role of leptin. , 1998, Archiv fur Tierernahrung.
[37] J. Callés-Escandon,et al. Menopause, central body fatness, and insulin resistance: effects of hormone‐replacement therapy , 1998, Coronary artery disease.
[38] M. K. James,et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. , 1997, The Journal of clinical endocrinology and metabolism.
[39] J Ashby,et al. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. , 1997, Regulatory toxicology and pharmacology : RTP.
[40] C. Darimont,et al. Influence of Estrogenic Status on the Lipolytic Activity of Parametrial Adipose Tissue in Vivo: an in Situ Microdialysis Study. , 1997, Endocrinology.
[41] H. Genant,et al. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. , 1996, JAMA.
[42] E. Poehlman,et al. Changes in Energy Balance and Body Composition at Menopause: A Controlled Longitudinal Study , 1995, Annals of Internal Medicine.
[43] P. Amouyel,et al. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. , 1995, Atherosclerosis.
[44] R. Miksicek. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[45] T. Buchanan,et al. Original ArticlesComparison of Estimates of Insulin Sensitivity in Pre- and Postmenopausal Women Using the Insulin Tolerance Test and the Frequently Sampled Intravenous Glucose Tolerance Test , 1994 .
[46] T. Buchanan,et al. Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. , 1994, Journal of the Society for Gynecologic Investigation.
[47] J. Auwerx,et al. Effects of sex steroids on hepatic and lipoprotein lipase activity and mRNA in the rat. , 1993, Hormone research.
[48] M. Zamboni,et al. Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[49] F. Vocci,et al. Extrapolation of animal toxicity data to man. , 1988, Regulatory toxicology and pharmacology : RTP.
[50] I W Davidson,et al. Biological basis for extrapolation across mammalian species. , 1986, Regulatory toxicology and pharmacology : RTP.
[51] P. Southwell-keely,et al. The oestrogenicity of equol in sheep. , 1984, The Journal of endocrinology.
[52] M. Greenwood,et al. Effect of Estrogen on Lipoprotein Lipase Activity and Cytoplasmic Progestin Binding Sites in Lean and Obese Zucker Rats , 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[53] G. Wade,et al. Food intake, body weight, and adiposity in female rats: actions and interactions of progestins and antiestrogens. , 1981, The American journal of physiology.
[54] Y. Chao,et al. Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. , 1980, The Journal of biological chemistry.
[55] E. Roy,et al. Role of estrogens in androgen-induced spontaneous activity in male rats. , 1975, Journal of comparative and physiological psychology.
[56] M. Hamosh,et al. The effect of estrogen on the lipoprotein lipase activity of rat adipose tissue. , 1975, The Journal of clinical investigation.
[57] C. P. Richter,et al. Comparison of the effects of gonadectomy of spontaneous activity of wild and domesticated Norway rats. , 1954, Endocrinology.
[58] G. Haslewood,et al. Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine. , 1932, Biochemical Journal.